Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,412 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer.
Shah PD, Wethington SL, Pagan C, Latif N, Tanyi J, Martin LP, Morgan M, Burger RA, Haggerty A, Zarrin H, Rodriguez D, Domchek S, Drapkin R, Shih IM, Smith SA, Dean E, Gaillard S, Armstrong D, Torigian DA, Hwang WT, Giuntoli R, Simpkins F. Shah PD, et al. Among authors: rodriguez d. Gynecol Oncol. 2021 Nov;163(2):246-253. doi: 10.1016/j.ygyno.2021.08.024. Epub 2021 Oct 5. Gynecol Oncol. 2021. PMID: 34620496 Free PMC article. Clinical Trial.
Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor-Resistant Homologous Recombination-Deficient Ovarian Cancer.
Wethington SL, Shah PD, Martin L, Tanyi JL, Latif N, Morgan M, Torigian DA, Rodriguez D, Smith SA, Dean E, Domchek SM, Drapkin R, Shih IM, Brown EJ, Hwang WT, Armstrong DK, Gaillard S, Giuntoli R, Simpkins F. Wethington SL, et al. Among authors: rodriguez d. Clin Cancer Res. 2023 Aug 1;29(15):2800-2807. doi: 10.1158/1078-0432.CCR-22-2444. Clin Cancer Res. 2023. PMID: 37097611
Longitudinal analysis of SARS-CoV-2 IgG antibody durability in Puerto Rico.
Madewell ZJ, Graff NE, Lopez VK, Rodriguez DM, Wong JM, Maniatis P, Medina FA, Muñoz JL, Briggs-Hagen M, Adams LE, Rivera-Amill V, Paz-Bailey G, Major CG. Madewell ZJ, et al. Among authors: rodriguez dm. Sci Rep. 2024 Dec 28;14(1):30743. doi: 10.1038/s41598-024-80465-4. Sci Rep. 2024. PMID: 39730470 Free PMC article.
Shifting Extraocular Motility in a Patient With Burkitt Lymphoma.
Nolan RP, Rodriguez DA, Mathew AJ, Mudie LI, Yen MT. Nolan RP, et al. Among authors: rodriguez da. Ophthalmic Plast Reconstr Surg. 2024 Oct 8. doi: 10.1097/IOP.0000000000002791. Online ahead of print. Ophthalmic Plast Reconstr Surg. 2024. PMID: 39724668 No abstract available.
2,412 results